Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma

Satoshi Kawano(Eisai (Japan)), Heike Keilhack(Epizyme (United States))
PLoS ONE
July 8, 2016
Cited by 76


Related Papers